biotech
157,179 ogledov
221 razprav
Vroče
Najnovejše
VITALIK DUMPING 6183 ETH!
Entry: 2140 🟩
Target 1: 2200 🎯
Stop Loss: 2100 🛑
The biggest ETH move of 2026 just dropped. Vitalik sold over 6183 ETH, worth $13.24 million. This isn't panic. It's a calculated move for massive ecosystem growth. Funds are pouring into vital AI safety, biotech, and security projects. Kanro, his biotech venture, is a major beneficiary. Vitalik is strategically selling in small batches to protect retail. This is FUEL for the future, not a sell-off. Don't miss this strategic shift. 10,000 ETH remains in his planned allocation.
News is for reference, not investment advice.
$ETH #CryptoNews #VitalikButerin #Aİ #Biotech 🚀
Entry: 2140 🟩
Target 1: 2200 🎯
Stop Loss: 2100 🛑
The biggest ETH move of 2026 just dropped. Vitalik sold over 6183 ETH, worth $13.24 million. This isn't panic. It's a calculated move for massive ecosystem growth. Funds are pouring into vital AI safety, biotech, and security projects. Kanro, his biotech venture, is a major beneficiary. Vitalik is strategically selling in small batches to protect retail. This is FUEL for the future, not a sell-off. Don't miss this strategic shift. 10,000 ETH remains in his planned allocation.
News is for reference, not investment advice.
$ETH #CryptoNews #VitalikButerin #Aİ #Biotech 🚀
$BIO Market Update 📉
The market for $BIO is currently in a bearish phase.
· 📉 Traders: Caution is advised; short opportunities may exist.
· ⚠️ Sellers: Consider securing positions or exiting.
· 🔍 Buyers: Wait for stronger signals or deeper support before entering.
Monitor the trend closely and manage risk. 🛡️
---$BIO
#BIO #Crypto #Trading #Bearish #Biotech
The market for $BIO is currently in a bearish phase.
· 📉 Traders: Caution is advised; short opportunities may exist.
· ⚠️ Sellers: Consider securing positions or exiting.
· 🔍 Buyers: Wait for stronger signals or deeper support before entering.
Monitor the trend closely and manage risk. 🛡️
---$BIO
#BIO #Crypto #Trading #Bearish #Biotech
🏛️ The ₹100 Billion Biopharma Blueprint
In a week of heavy "Risk-Off" sentiment for the crypto and global markets, the Indian pharmaceutical sector has found its own "Green Zone." Following the Union Budget 2026 announcement, the NIFTY Pharma Index climbed 0.9%, as investors reacted to a massive multi-year commitment from the government.
Here is why the "Pharmacy of the World" is shifting into high gear and why this matters for your 2026 portfolio.
The Indian government has officially moved beyond simple generic manufacturing. Finance Minister Nirmala Sitharaman’s proposal to allocate 100 billion rupees ($1.2 Billion) specifically for the biopharmaceutical sector over the next five years is a strategic pivot toward high-value innovation.
The "Value" Shift
For decades, India dominated the volume of global generics. This new budget marks a transition to:
Biosimilars & Complex Generics: Moving up the value chain where margins are higher and competition is more technical.
Cell & Gene Therapy: Providing the capital needed for Indian startups to lead in next-gen curative therapies.
Global Regulatory Alignment: A push to align India’s drug regulator with international standards, making it easier for local firms to get FDA and EU approvals faster.
Why the Market is Bullish
The 0.9% jump in the NIFTY Pharma Index might seem modest compared to crypto volatility, but in the equity world, it represents billions in institutional confidence.
Long-Term Visibility: A 5-year funding roadmap gives companies like Sun Pharma, Dr. Reddy’s, and Biocon the certainty to invest in long-term R&D.
Infrastructure Boost: The budget includes provisions for high-tech tool rooms and specialized laboratory infrastructure within the 200 rejuvenated industrial clusters.
Innovation Incentives: While the industry is still pushing for the restoration of the 200% Weighted R&D Deduction, the 100-billion-rupee injection is seen as a strong "down payment" on India's future as a global biotech hub.
💬 Vibe Check: Is Pharma the New Tech?
As AI-driven drug discovery becomes the norm in 2026, do you see the Indian pharma sector becoming as dominant as its IT sector? Are you diversifying your 2026 gains into traditional "Value" sectors like Biopharma? 🧪🧬
Drop your thoughts on India's "Innovation Era" in the comments! 👇
#NiftyPharma #IndiaBudget2026 #Biotech #Investing2026 #BinanceSquare $BTC $BNB
Here is why the "Pharmacy of the World" is shifting into high gear and why this matters for your 2026 portfolio.
The Indian government has officially moved beyond simple generic manufacturing. Finance Minister Nirmala Sitharaman’s proposal to allocate 100 billion rupees ($1.2 Billion) specifically for the biopharmaceutical sector over the next five years is a strategic pivot toward high-value innovation.
The "Value" Shift
For decades, India dominated the volume of global generics. This new budget marks a transition to:
Biosimilars & Complex Generics: Moving up the value chain where margins are higher and competition is more technical.
Cell & Gene Therapy: Providing the capital needed for Indian startups to lead in next-gen curative therapies.
Global Regulatory Alignment: A push to align India’s drug regulator with international standards, making it easier for local firms to get FDA and EU approvals faster.
Why the Market is Bullish
The 0.9% jump in the NIFTY Pharma Index might seem modest compared to crypto volatility, but in the equity world, it represents billions in institutional confidence.
Long-Term Visibility: A 5-year funding roadmap gives companies like Sun Pharma, Dr. Reddy’s, and Biocon the certainty to invest in long-term R&D.
Infrastructure Boost: The budget includes provisions for high-tech tool rooms and specialized laboratory infrastructure within the 200 rejuvenated industrial clusters.
Innovation Incentives: While the industry is still pushing for the restoration of the 200% Weighted R&D Deduction, the 100-billion-rupee injection is seen as a strong "down payment" on India's future as a global biotech hub.
💬 Vibe Check: Is Pharma the New Tech?
As AI-driven drug discovery becomes the norm in 2026, do you see the Indian pharma sector becoming as dominant as its IT sector? Are you diversifying your 2026 gains into traditional "Value" sectors like Biopharma? 🧪🧬
Drop your thoughts on India's "Innovation Era" in the comments! 👇
#NiftyPharma #IndiaBudget2026 #Biotech #Investing2026 #BinanceSquare $BTC $BNB
$WLD IS THE NEW KING! OPENAI BIO-SOCIAL EXPLOSION ROCKS THE MARKET!
$WLD is already pumping because the Orb is becoming the sole passport against AI spam. If Altman replaces logins with biometrics, $WLD becomes the human currency.
Buy the fear while bots can still post on $X! Open those long positions NOW.
#Worldcoin #CryptoAlpha #SamAltman #BioTech 🚀
$WLD is already pumping because the Orb is becoming the sole passport against AI spam. If Altman replaces logins with biometrics, $WLD becomes the human currency.
Buy the fear while bots can still post on $X! Open those long positions NOW.
#Worldcoin #CryptoAlpha #SamAltman #BioTech 🚀
Buenas, me gustaría saber vuestra opinión acerca de bloquear $BNB para la obtención de tokens BIO protocol. ¿Creéis que es interesante? #Biotech #BIOprotocol
🤖An idea of monetization and tokenization of pharmaceutical product royalties
1.Fundraising as a fund.
2.Monetization - Invest the royalties of drugs still in the R&D phase.
3.Tokenization - design a token distribution plan that should cover the clinical volunteer community.
4.Return the tokens to the GPs and LPs of the fund, and start the public trading. Keep updated with the announcements of the timely clinical research progress.
This design would enable pharmaceutical startups, LPs, and doctor-patient communities to realize value returns while shortening the capital cycle.
We are committed to integrating web3 with biotech for a more comprehensive development.
#Biotech
1.Fundraising as a fund.
2.Monetization - Invest the royalties of drugs still in the R&D phase.
3.Tokenization - design a token distribution plan that should cover the clinical volunteer community.
4.Return the tokens to the GPs and LPs of the fund, and start the public trading. Keep updated with the announcements of the timely clinical research progress.
This design would enable pharmaceutical startups, LPs, and doctor-patient communities to realize value returns while shortening the capital cycle.
We are committed to integrating web3 with biotech for a more comprehensive development.
#Biotech
Positive
100%
Negative
0%
1 glasov • Glasovanje zaključeno
Are you ready to invest in the future of biotechnology? 🔬 Binance Launchpad is set to feature BIO Protocol, a decentralized platform poised to revolutionize the industry. But before you jump into the investment pool, let's take a deep dive and learn more about this exciting project!
BIO Protocol is a curation and liquidity platform designed specifically for Decentralized Science (DeSci). 🧬 Their mission is to accelerate biotechnology by empowering global communities of patients, scientists, and biotech professionals. 👨🔬👩🔬 This is achieved by providing the tools and infrastructure for these communities to collectively fund, build, and own tokenized biotech projects and intellectual property (IP). 💡
The team behind BIO Protocol has a strong track record in the DeSci space. 💪 They were instrumental in creating Molecule, a platform for tokenizing early-stage biomedicine, and VitaDAO, a prominent decentralized community focused on longevity science. 🧬
BIO Protocol aims to catalyze an on-chain scientific economy through decentralized funding, incentives, and liquidity. 💰 The BIO token grants holders access to BIO's network of scientific communities and IP, providing broad exposure to the DeSci ecosystem. 🌐
Investing in BIO Protocol? 🚀
* DYOR! 🧐 Do your own research and understand the project's risks and potential rewards.
* Invest responsibly! ⚠️ Cryptocurrency investing carries inherent risks.
#binancelaunchpad #BIOProtocol #DeSci #Biotech #DYOR
BIO Protocol is a curation and liquidity platform designed specifically for Decentralized Science (DeSci). 🧬 Their mission is to accelerate biotechnology by empowering global communities of patients, scientists, and biotech professionals. 👨🔬👩🔬 This is achieved by providing the tools and infrastructure for these communities to collectively fund, build, and own tokenized biotech projects and intellectual property (IP). 💡
The team behind BIO Protocol has a strong track record in the DeSci space. 💪 They were instrumental in creating Molecule, a platform for tokenizing early-stage biomedicine, and VitaDAO, a prominent decentralized community focused on longevity science. 🧬
BIO Protocol aims to catalyze an on-chain scientific economy through decentralized funding, incentives, and liquidity. 💰 The BIO token grants holders access to BIO's network of scientific communities and IP, providing broad exposure to the DeSci ecosystem. 🌐
Investing in BIO Protocol? 🚀
* DYOR! 🧐 Do your own research and understand the project's risks and potential rewards.
* Invest responsibly! ⚠️ Cryptocurrency investing carries inherent risks.
#binancelaunchpad #BIOProtocol #DeSci #Biotech #DYOR
“Il cancro ama lo zucchero.
Noi lo nutriamo di zucchero.
Poi accendiamo la luce. E muore.” 🔦
Questa è Photodynamic Therapy.
Già in trials. Già reale.
Non hype → Conviction.
#DeSci #Bio #Biotech #BİNANCE #FutureTradingSignals #FutureOfHealth 🚀
Noi lo nutriamo di zucchero.
Poi accendiamo la luce. E muore.” 🔦
Questa è Photodynamic Therapy.
Già in trials. Già reale.
Non hype → Conviction.
#DeSci #Bio #Biotech #BİNANCE #FutureTradingSignals #FutureOfHealth 🚀
Here’s a more creative and attractive Binance Square post for $BIO 👇
🚀 $BIO
– Where Biotech Meets Blockchain 🔬💎
While meme coins come and go, $BIO is building real-world utility. Combining Biotechnology + Blockchain, this project is tapping into a trillion-dollar future industry. 🌍✨
👉 The smart money moves early. Are you in before Wall Street notices?
#BIO #Biotech #CryptoGems #Altcoins #BinanceSquare
– Where Biotech Meets Blockchain 🔬💎
While meme coins come and go, $BIO is building real-world utility. Combining Biotechnology + Blockchain, this project is tapping into a trillion-dollar future industry. 🌍✨
👉 The smart money moves early. Are you in before Wall Street notices?
#BIO #Biotech #CryptoGems #Altcoins #BinanceSquare
#DeSci is the future — not a meme.🙏
$BIO isn't just another token.
It’s a sleeping giant about to tear through the market.
@BIO Protocol is building real-world #Biotech solutions in a trillion-dollar industry.
While the weak hands fled during the storm,#BIO only got stronger.
In crypto, the ones who suffered the most often become the biggest winners.
#BİO is about to explode.
Don’t say you weren’t warned.
$BIO isn't just another token.
It’s a sleeping giant about to tear through the market.
@BIO Protocol is building real-world #Biotech solutions in a trillion-dollar industry.
While the weak hands fled during the storm,#BIO only got stronger.
In crypto, the ones who suffered the most often become the biggest winners.
#BİO is about to explode.
Don’t say you weren’t warned.
$BIO Token is a blockchain-based utility token focused on revolutionizing healthcare and biotech data management.
Its bullish move is driven by growing adoption in medical research and decentralized data storage.
🔶 Tokenomics include a fixed supply of 1 billion tokens:-
✅40% for public sale ✅20% for ecosystem growth
✅20% for development
✅10% for partnerships
✅10% reserved.
Staking rewards, low transaction fees, and utility in data licensing add long-term value and investor confidence.
$BTC
#BIO #Biotech #BİO #bnb #BTC
Its bullish move is driven by growing adoption in medical research and decentralized data storage.
🔶 Tokenomics include a fixed supply of 1 billion tokens:-
✅40% for public sale ✅20% for ecosystem growth
✅20% for development
✅10% for partnerships
✅10% reserved.
Staking rewards, low transaction fees, and utility in data licensing add long-term value and investor confidence.
$BTC
#BIO #Biotech #BİO #bnb #BTC
BIO Protocol (BIO) is transforming biotech with decentralized science (DeSci), allowing communities to fund and own biotech projects. Explore its tokenomics and ecosystem utility in KuCoin's latest research report.
#DeSci $BIO
#Blockchain #Biotech
#DeSci $BIO
#Blockchain #Biotech
Bio protocol coin
With Bio Protocol Coin, the possibilities are endless. Imagine a world where medical breakthroughs are accelerated, and life-changing treatments are developed faster. Join the conversation and let's shape the future of biotech together!#Biotech #BTCUnbound
With Bio Protocol Coin, the possibilities are endless. Imagine a world where medical breakthroughs are accelerated, and life-changing treatments are developed faster. Join the conversation and let's shape the future of biotech together!#Biotech #BTCUnbound
🐕 #Biotech is the talk of the TOWN , #BIO hits almost 50% in 24 hrs window. Will it accelerate to the ATH during this #altsesaon ?
🐕Cryptocurrency investments carry risks. Therefore, this is not financial advice (No BSH recommendation). Hence please do your own research (DYOR) before making investment decisions.
#Write2Earn
#Write2Earn!
$BIO
🐕Cryptocurrency investments carry risks. Therefore, this is not financial advice (No BSH recommendation). Hence please do your own research (DYOR) before making investment decisions.
#Write2Earn
#Write2Earn!
$BIO
💡 Why I’m Bullish on $BIO
Unlike meme coins with no utility, BIO is bridging biotechnology + blockchain. The global biotech industry is worth $2 trillion, and BIO is building a transparent, decentralized funding model for it. When adoption hits, prices won’t be under $1 again.
Buy $BIO today and hold for the future.
#Biotech #CryptoRally #PowellWatch #
Unlike meme coins with no utility, BIO is bridging biotechnology + blockchain. The global biotech industry is worth $2 trillion, and BIO is building a transparent, decentralized funding model for it. When adoption hits, prices won’t be under $1 again.
Buy $BIO today and hold for the future.
#Biotech #CryptoRally #PowellWatch #
Prijavite se, če želite raziskati več vsebin